Supernus Pharmaceuticals Inc. SUPN
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) disorders. Its primary function is to innovate therapeutic solutions that address unmet medical needs in neurology and psychiatry. Known for its robust…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees674
TickerSUPN
Statistics
Market Cap$2.52B
Revenue (TTM)$719.0M
Net Income-$38.5M
Net Margin-5.4%
EPS$-0.51
P/E40.66
P/S3.37
P/B2.44
EV/EBITDA18.54
ROE-2.8%
Dividend Yield—
Price$43.44
Data: Twelve Data · Revenue = mcap / P/S